Role of low plasma volume treatment on clinical efficacy of plasmapheresis in neuromyelitis optica

BACKGROUND: Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Plasmapheresis (PP) is an effective adjunct therapy in severe NMO attacks. The recommended minimum plasma volume to be treated per session of PP is equivalent to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Akshay, Periyavan, Sundar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613414/
https://www.ncbi.nlm.nih.gov/pubmed/28970675
http://dx.doi.org/10.4103/ajts.AJTS_111_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613414/
https://www.ncbi.nlm.nih.gov/pubmed/28970675
http://dx.doi.org/10.4103/ajts.AJTS_111_16

Ejemplares similares